Blood vessel wall interactions in diabetes

Diabetes

Volumn 46, Issue SUPPL. 2, 1997, Pages

  Schrör, Karsten ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; INSULIN;

BLOOD VESSEL PERMEABILITY; BLOOD VESSEL TONE; BLOOD VESSEL WALL; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHY; FIBRINOLYSIS; GLYCATION; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; THROMBOEMBOLISM; VASCULAR ENDOTHELIUM;

EID: 0030955173     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.2.s115     Document Type: Conference Paper

References (53)

1. Nathan DM: Long-term complications of diabetes mellitus. N Engl J Med 328:1676-1685, 1993
2. Tesfamariam B: Free radicals in diabetic endothelial cell dysfunction. Free Radic Biol Med 16:383-391, 1994
3. Ceriello A: Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects. Diabetologia 36:1119-1125, 1993
4. Mustard JF, Packham MA: Platelets and diabetes mellitus. N Engl J Med 311:665-667, 1984
5. Auwerxs J, Boullion R, Collen D, Geboers J: Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis 8:68-72, 1988
6. Lorenzi M, Cagliero E: Pathobiology of endothelial and other vascular cells in diabetes mellitus: call for data. Diabetes 40:653-659, 1991
7. Vane JR, Anggard EE, Botting RM: Regulatory functions of the vascular endothelium. N Engl J Med 323:27-36, 1990
8. Wolffenbuttel BHR, van Haeften TW: Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM). Drugs 50:263-288, 1995
9. Reaven GM: Pathophysiology of insulin resistance in human disease. Physiol Rev 75:473-486, 1995
10. Calver AC, Collier JG, Vallance PJT: Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 90:2548-2554, 1992
11. Cerami A, Vlassara H, Brownlee M: Role of advanced glycosylation products in complications of diabetes. Diabetes Care 11 (Suppl. 1):73-79, 1988
12. Schneider SL, Cohn RR: Glucosylation of human collagen in aging and diabetes mellitus. J Clin Invest 66:1179-1181, 1980
13. Vlassara H, Fuh H, Makita Z, Krungkrai S, Cerami A, Bucala R: Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc, Natl Acad Sci USA 89:12043-12047, 1992
14. Bucala R, Tracey KJ, Cerami A: Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 87:432-438, 1991
15. Charonis AS, Tsilibary EC: Structural and functional changes of laminin and type IV collagen after nonenzymatic glycation. Diabetes 41 (Suppl. 2):49-51, 1992
16. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation endproducts in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321, 1988
17. Hunt JV, Smith CCT, Wolff SP: Autooxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39:1420-1424, 1990
18. Rosen GM, Freeman SA: Detection of Superoxide generated by endothelial cells. Proc Natl Acad Sci USA 81:7269-7273, 1984
19. Tesfamariam B, Cohen RA: Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 263:H321-H323, 1992
20. DeWitt DL, Day JS, Sonnenburg WKJ, Smith WL: Concentrations of prostaglandin endoperoxide synthase and prostaglandin 12 synthase in the endothelium and smooth muscle of bovine aorta. J Clin Invest 72:1882-1888, 1983
21. Tesfamariam B, Brown ML, Deykin D, Cohen RA: Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest 85:929-932, 1990
22. Gopaul NK, Anggard EE, Mallet AI, Betteridge DJ, Wolff SP, Nourooz-Zadeh J: Plasma 8-epi-PGF2a levels are elevated in individuals with non-insulin-dependent diabetes mellitus. FEBS Lett 368:225-229, 1995
23. Babiy AV, Gebicki JM, Sulliovan DR, Willey K: Increased oxidizanolity of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation. Biochem Pharmacol 43:995-1000, 1992
24. Hattori Y, Kawasaki H, Abe K, Kanno M: Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 263:H676-H680, 1991
25. Rösen P, Ballhausen T, Bloch W, Addicks K: Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: influence of tocopherol as antioxidant. Diabetologia 38:1157-1168, 1995
26. Ostermann H, van de Loo J: Factors of the hemostatic system in diabetic patients: a survey of controlled studies. Haemostasis 16:386-416, 1986
27. Jones RL, Peterson CM: Reduced fibrinogen survival in diabetes mellitus: a reversible phenomenon. J Clin Invest 63:485-493, 1979
28. Jones RL: Fibrinopeptide A in diabetes mellitus: relation to levels of blood glucose, fibrinogen disappearance, and hemodynamic changes. Diabetes 34:836-841, 1985
29. Myrup B, Rossing P, Jensen T, Gram J, Kluft C, Jespersen J: Procoagulant activity and intimal dysfunction in IDDM. Diabetologia 38:73-78, 1995
30. Ceriello A, Giacomello R, Stel G, Motz E, Taboga C, Tonutti L, Pirisi M, Falleti E, Bartoli E: Hyperglycemia-induced thrombin formation in diabetes: the possible role of oxidative stress. Diabetes 44:924-928, 1995
31. Giddings JC: Cytokines and thrombomodulin. In The Endothelium: An Introduction to Current Research. Warren JB, Ed. New York, Wiley-Liss, 1990, p. 141-156
32. Iwashima Y, Sato T, Watanabe K, Ooshima E, Hiraishi S, Ishii H, Kazama M, Makino I: Elevation of plasma thrombomodulin level in diabetic patients with early diabetic nephropathy. Diabetes 39:983-988, 1990
33. Krugluger W, Kopp H-P, Schernthaner G, Hopmeier P: Enhanced anticoagulant response to activated protein C in patients with IDDM. Diabetes 44:1033-1037, 1995
34. Tani N, Hada K, Kitami A, Nakano M, Takahashi H, Ito S, Sato I, Shibata A: Effects of acetyl salicylic acid and cilostazol administration on serum thrombomodulin concentration in diabetic patients. Thromb Res 69:153-158, 1993
35. Nemerson Y: Tissue factor and hemostasis. Blood 71:1-8, 1988
36. Rao LVM, Rapaport SI: Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation. Blood 69:645-651, 1987
37. Boeri D, Almus FE, Maiello M, Cagliero E, Rao LVM, Lorenzi M: Modification of tissue-factor mRNA and protein response to thrombin and interleukin-1 by high glucose in cultured human endothelial cells. Diabetes 38:212-218, 1989
38. Leurs PB, van Oerle R, Hamulyak K, Wolffenbuttel HR: Tissue factor pathway inhibitor activity in patients with IDDM. Diabetes 45:80-84, 1995
39. Collier A, Rumley A, Rumley AG, Paterson JR, Leach JP, Lowe GDO, Small M: Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria. Diabetes 41:909-913, 1992
40. Cagliero E, Roth T, Roy S, Lorenzi M: Characteristics and mechanisms of high glucose-induced overexpression of basement membrane components in cultured human endothelial cells. Diabetes 40:101-110, 1991
41. Davi G, Catalano I, Averna M: Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med 322:1769-1774, 1990
42. Halushka PV, Rogers RC, Loadhold CB, Colwell JA Increased platelet-thromboxane synthesis in diabetes mellitus. J Lab Clin Med 97:87-96, 1981
43. Kaplan KL: Laboratory markers of platelet activation. In Haemostasia and Thrombosis: Basic Principles and Clinical Praxis. Colman RW, Hirsh J, Marder VJ, Eds. Philadelphia, JB Lippincott, 1994, p. 1180-1196
44. Tschoepe D, Driesch E, Schwippert B, Nieuwenhuis H-K, Gries FA: Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalized by near-normoglycemia. Diabetes 44:890-894, 1995
45. Tschöpe D, Schwippert B, Schettler B, Kiesel U, Rothe H, Roesen P, Gries FA Increased GPIIb/IIIa expression and altered DNA-ploidy pattern in megakariocytes of diabetic BB-rats. Eur J Clin Invest 22:591-598, 1992
46. Tschöpe D, Schwippert B, Raie I, Schmidt-Soltau C, Rösen P: Wirkung von Azetylsalizylsäure auf die intravasale Thrombozytenaktivierung bei Typ-I-Diabetikern: eine Pilotstudie. Diabetes Stoffwechsel 3:391-396, 1994
47. Vane JR, Anggard EE, Botting RM: Regulatory functions of the vascular endothelium. N Engl J Med 323:27-36, 1990
48. Ono H, Umeda F, Inoguchi T, Ibayashi H: Glucose inhibits prostacyclin production by cultured aortic endothelial cells. Thromb Haemost 60:174-177, 1988
49. Oliver FJ, de la Rubia G, Feener EP, Lee M, Loeken MR, Shiba T, Quertemous T, King GL: Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J Biol Chem 266:23251-23256, 1991
50. Takahashi K, Ghatei MA, Lam HC, O'Halloran DJ, Bloom SR: Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 33:306-310, 1990
51. Tooke JE: Microvascular haemodynamics in diabetes mellitus. Clin Sci 70:119-125, 1986
52. Stehouwer CDA, Nauta JJP, Zeldenrust GC, Hackeng WHL, Donker AJM, den Ottolander GJH: Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin dependent diabetes mellitus. Lancet 340:319-323, 1992
53. Stehouwer CDA, Fischer HRA, van Kuijk AWR, Polak BCP, Donker AJM: Endothelial dysfunction preceded development of microalbuminuria in IDDM. Diabetes 44:561-564, 1995